KATHLEEN SMITH: Open Payments
NPI 1568749695 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 10 payments from 7 companies in 2025. Trend: 2023 $122 · 2024 $35 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Gilead Sciences, Inc. | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| ABBVIE INC. | 1 | $27 |
| Caris MPI, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OPDIVO, Trodelvy, Enhertu, ELAHERE, MI CANCER SEEK, Vanflyta, ZEJULA, JEMPERLI.
Industry payments across PA — which companies pay providers there.
